Patent Assignment
Reel/Frame 039207/0404
Corrective Assignment to Correct the Execution Date for Klaus Edvardsen Previously Recorded at Reel: 013692 Frame: 0021. Assignor(S) Hereby Confirms the Assignment .
Recorded: 2016-06-29
Pages: 6
Assignors
CHAPLIN, DAVID J.
Executed: 2002-12-10
PREZIOSO, JOSEPH ANTHONY
Executed: 2002-12-10
EDVARDSEN, KLAUS
Executed: 2003-01-15
Assignee
OXIGENE, INC.
701 GATEWAY BOULEVARD, SUITE 210, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property
(1)
Functionalized Stilbene Derivatives as Improved Vascular Targeting Agents
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 23, 2003
From: CHAPLIN, DAVID J.; PREZIOSO, JOSEPH ANTHONY; EDVARDSEN, KLAUS
To: OXIGENE, INC.
Reel/Frame 013692/0021 →
Assignment of Assignor's Interest
May 11, 2004
From: GARNER, CHARLES M., III; KANE, ROBERT R.; PINNEY, KEVIN G.
To: BAYLOR UNIVERSITY
Reel/Frame 015314/0848 →
Change of Assignee Address
Mar 10, 2008
From: OXIGENE, INC.
To: OXIGENE, INC.
Reel/Frame 020617/0673 →
Change of Name
Jul 26, 2016
From: OXIGENE, INC.
To: MATEON THERAPEUTICS, INC.
Reel/Frame 039264/0377 →